<p>Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database</p>

Abstract

This study revealed that favipiravir appears to be a relatively safe drug. An undiscovered anti-inflammatory activity of favipiravir may explain the improvement in critically ill patients and reduce inflammatory markers. Currently, the data is based on very few patients. A more detailed assessment of the uncommon ADEs needs to be analyzed when more information will be available.